In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
ReShape Lifesciences Inc (NASDAQ: RSLS) closed the day trading at $2.46 down -6.11% from the previous closing price of $2.62. In other words, the price has decreased by -$6.11 from its previous closing price. On the day, 1.02 million shares were traded.
Ratios:
For a better understanding of RSLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.53. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.01.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.82 while its Price-to-Book (P/B) ratio in mrq is 0.27.
Stock Price History:
Over the past 52 weeks, RSLS has reached a high of $414.99, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is -59.90%, while the 200-Day Moving Average is calculated to be -96.88%.
Shares Statistics:
A total of 2.39M shares are outstanding, with a floating share count of 2.19M. Insiders hold about 8.37% of the company’s shares, while institutions hold 10.04% stake in the company.
